Outcome and prognostic variables in childhood rhabdomyosarcoma (RMS) with emphasis on impact of FOXO1 fusions in non-metastatic RMS: experience from a tertiary cancer centre in India.

Ramanathan, Subramaniam; Sisodiya, Sneha; Shetty, Omshree; Prasad, Maya; Parambil, Badira C; Shah, Sneha; Ramadwar, Mukta; Khanna, Nehal; Laskar, Siddhartha; Qureshi, Sajid; Vora, Tushar; Chinnaswamy, Girish

Ramanathan, Subramaniam; Sisodiya, Sneha; Shetty, Omshree; Prasad, Maya; Parambil, Badira C; Shah, Sneha; Ramadwar, Mukta; Khanna, Nehal; Laskar, Siddhartha; Qureshi, Sajid; Vora, Tushar; Chinnaswamy, Girish.

Afiliação

Ramanathan S; Trust Doctor, Department of Paediatric Oncology, Great North Children's Hospital, Royal Victoria Infirmary, Newcastle-Upon-Tyne, NE1 8SG, UK.
Sisodiya S; Department of Pathology, Lokmanya Tilak Municipal General Hospital & Medical College, Mumbai 400022, India.
Shetty O; Division of Molecular Pathology, Department of Pathology, Tata Memorial Hospital, Mumbai 400012, India.
Prasad M; Homi Bhabha National Institute, Mumbai 400094, India.
Parambil BC; Homi Bhabha National Institute, Mumbai 400094, India.
Shah S; Department of Pediatric Oncology, Tata Memorial Hospital, Mumbai 400012, India.
Ramadwar M; Homi Bhabha National Institute, Mumbai 400094, India.
Khanna N; Department of Pediatric Oncology, Tata Memorial Hospital, Mumbai 400012, India.
Laskar S; Homi Bhabha National Institute, Mumbai 400094, India.
Qureshi S; Department of Nuclear Medicine, Tata Memorial Hospital, Mumbai 400012, India.
Vora T; Homi Bhabha National Institute, Mumbai 400094, India.
Chinnaswamy G; Department of Pathology, Tata Memorial Hospital, Mumbai 400012, India.